| Erin Rae Cocchiola, AU D | |
|
1601 Clint Moore Rd, #105, Boca Raton, FL 33487-2768 | |
| (561) 939-0173 | |
| Not Available |
| Full Name | Erin Rae Cocchiola |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 14 Years |
| Location | 1601 Clint Moore Rd, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104132364 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AY1640 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Associates Of Florida, Llc | 0042292849 | 196 |
News Archive
Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
A new issue brief from the Center for State and Local Government Excellence takes a hard look at the options state and local governments are pursuing to reduce their unfunded liabilities for retiree health care.
› Verified 3 days ago
| Provider Name | Ent And Allergy Associates Of Florida, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164473120 PECOS PAC ID: 0042292849 Enrollment ID: O20040604000553 |
News Archive
Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
A new issue brief from the Center for State and Local Government Excellence takes a hard look at the options state and local governments are pursuing to reduce their unfunded liabilities for retiree health care.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Rae Cocchiola, AU D 1601 Clint Moore Rd, #105, Boca Raton, FL 33487-2768 Ph: (561) 939-0173 | Erin Rae Cocchiola, AU D 1601 Clint Moore Rd, #105, Boca Raton, FL 33487-2768 Ph: (561) 939-0173 |
News Archive
Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
A new issue brief from the Center for State and Local Government Excellence takes a hard look at the options state and local governments are pursuing to reduce their unfunded liabilities for retiree health care.
› Verified 3 days ago
Kathryn F Jackson, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1601 Clint Moore Rd, Suite 105, Boca Raton, FL 33487 Phone: 561-393-9150 | |
Dr. Meredith Anderson Buemi, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7900 Glades Road, Suite 340, Boca Raton, FL 33433 Phone: 561-353-7377 | |
Active Life Hearing Audiologist Medicare: Medicare Enrolled Practice Location: 8903 Glades Rd Ste A14, Boca Raton, FL 33434 Phone: 561-221-0450 Fax: 954-827-0591 | |
Diana Barreneche, Inc Audiologist Medicare: Medicare Enrolled Practice Location: 7100 W Camino Real Ste 200, Boca Raton, FL 33433 Phone: 561-674-2859 Fax: 561-571-0316 | |
Labyrinth Audiology Audiologist Medicare: Medicare Enrolled Practice Location: 1500 Nw 10th Ave, Suite 104, Boca Raton, FL 33486 Phone: 561-807-7873 Fax: 561-807-7947 | |
Erin Elizabeth Anderson, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1601 Clint Moore Rd, Suite 105, Boca Raton, FL 33487 Phone: 561-393-9150 |